Free Trial
LON:LSIC

Lifeline Scientific (LSIC) Share Price, News & Analysis

Lifeline Scientific logo

About Lifeline Scientific Stock (LON:LSIC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,620 shs
Average Volume
4,120 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lifeline Scientific, Inc. is a developer of products and services for cell, tissue and organ transplantation. The Company is engaged in the business of delivering a portfolio of related technologies, which include devices, solutions and protocols designed to maximize the use and availability of organs, tissues and cells. Its business units include Organ Recovery Systems and Tissue Testing Technologies (T3). Organ Recovery Systems is the transplant community's provider of products and services for donor organ recovery, preservation and transport. T3 is a cryobiology research laboratory focused on developing approaches to preserve, transport, and evaluate biological living materials for transplantation, and other clinical and research applications. Its products include LifePort Kidney Transporter, LifePort Liver Transporter, Vasosol, Universal SealRing Cannula and LifePort WorkStation. It also offers SPS-1, a Static Preservation Solution and KPS-1, a Kidney Perfusion Solution.

Receive LSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifeline Scientific and its competitors with MarketBeat's FREE daily newsletter.

LSIC Stock News Headlines

A Lunar Lifeline for Endangered Species
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.
See More Headlines

LSIC Stock Analysis - Frequently Asked Questions

Shares of LSIC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lifeline Scientific investors own include TransMedics Group (TMDX) and Meta Platforms (META).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
LON:LSIC
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:LSIC) was last updated on 4/22/2025 by MarketBeat.com Staff
From Our Partners